1-2 of 2
Jason Chittenden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exposure-Response Analyses of Various Efficacy and Safety Endpoints in Support of Registrational Dose Selection of Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma

Oleg Milberg, Joannellyn Chiu, Anasuya Hazra, Sameer Upadhyay, Glenn S. Kroog, Karen Rodriguez Lorenc, John D. Davis, A. Thomas DiCioccio, Lutz O. Harnisch, Jason Chittenden
Journal: Blood
Blood (2024) 144 (Supplement 1): 7056.
https://doi.org/10.1182/blood-2024-200109
Published: 2024
Journal Articles

Selection of Odronextamab Pediatric Dosing Regimens for Aggressive Non-Hodgkin Lymphoma Via a Modeling and Simulation Approach

Min Zhu, Michael Dodds, Srikanth R. Ambati, Hesham Mohamed, Jason Chittenden, Hong Yan, Aafia Chaudhry, John D. Davis
Journal: Blood
Blood (2022) 140 (Supplement 1): 8855–8856.
https://doi.org/10.1182/blood-2022-158416
Published: 2022